Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine

Psychopharmacology
J L Wiley, Amelia D Compton

Abstract

Previous research has shown that rats exposed perinatally to phencyclidine (PCP) exhibited neuroanatomical abnormalities and altered cognition. In addition to cognitive deficits, schizophrenic patients may also exhibit negative symptoms such as lack of motivation. In this study, we used a progressive ratio (PR) schedule of food reinforcement to assess motivation following early exposure to PCP. Male rat pups were injected SC with 10 mg/kg PCP on postnatal days (PN) 7, 9, and 11. On PN 120, they began training in a PR 5 schedule of food reinforcement. Significant PCP effects on acquisition and baseline performance were not noted. After acquisition of the task, challenges with PCP, dizocilpine, amphetamine, haloperidol, and clozapine resulted in dose-dependent decreases in response rates of similar magnitudes in both groups. In rats that continued to respond at higher doses, PCP, dizocilpine, and clozapine failed to alter breakpoints. In contrast, a 5.6 mg/kg dose of amphetamine selectively increased breakpoints in PCP-treated rats, although very few rats responded at this dose. Haloperidol decreased breakpoints in most rats at non-sedating doses. These results suggest that a regimen of perinatal PCP administration sufficient to ...Continue Reading

References

Jan 1, 1992·Psychopharmacology·T J Hudzik, B L Slifer
Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Apr 1, 1990·Pharmacology, Biochemistry, and Behavior·G E Schulze, M G Paule
Sep 1, 1988·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Carlsson
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen, S Olsen
Nov 1, 1981·Pharmacology, Biochemistry, and Behavior·S A SegalD M Thompson
Jan 1, 1993·Psychopharmacology·A MarkouG F Koob
Aug 1, 1994·Pharmacology, Biochemistry, and Behavior·E A BuffaloM G Paule
Sep 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·B Moghaddam
Mar 1, 1994·Pharmacology, Biochemistry, and Behavior·R E SteinpreisJ D Salamone
Jan 1, 1996·Pharmacology, Biochemistry, and Behavior·S A Ferguson, M G Paule
Oct 1, 1996·Behavioral Neuroscience·M C Schmelzeis, G Mittleman
Jun 19, 1998·Pharmacology, Biochemistry, and Behavior·S M TurgeonM A Heller
Nov 5, 1998·Pharmacology, Biochemistry, and Behavior·J E AbermanJ D Salamone
Jun 17, 1999·Pharmacology, Biochemistry, and Behavior·S Reilly
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R M KirraneL J Siever
Dec 5, 2000·Behavioural Pharmacology·B A Ellenbroek, A R Cools
Feb 15, 2001·Archives of General Psychiatry·B KirkpatrickW T Carpenter
Mar 29, 2001·Pharmacology, Biochemistry, and Behavior·W F Caul, N A Brindle
Apr 15, 2003·Toxicology and Applied Pharmacology·Tsung-Ming ShihJohn H McDonough
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cecile Spielewoy, Athina Markou
Aug 19, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jenny L WileyKenneth M Johnson
Dec 4, 2003·Pharmacology, Biochemistry, and Behavior·Sarah M Turgeon, Stephen G Hoge

❮ Previous
Next ❯

Citations

Jan 1, 2013·Behavioural Brain Research·Karly M TurnerThomas H J Burne
Nov 13, 2015·Genes, Brain, and Behavior·S A Schoenrock, Lisa M Tarantino
Mar 20, 2012·Pharmacology, Biochemistry, and Behavior·Julie A Marusich, Jenny L Wiley
Sep 5, 2006·Neuron·Barbara CagniardXiaoxi Zhuang
Sep 26, 2015·Pharmacological Reviews·Esa R KorpiGavin S Dawe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here